Interval Debulking Surgery in Patients with Federation of Gynecology and Obstetrics (FIGO) Stage IIIC and IV Ovarian Cancer

Publisher： Karger

E-ISSN： 2296-5262|36|6|324-332

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.36, Iss.6, 2013-05, pp. : 324-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Interval Debulking Surgery on Clinical Outcome in Primary Unresectable FIGO Stage IIIc Ovarian Cancer Patients

By  

Oncology, Vol. 65, Iss. 4, 2004-01 ,pp. : 316-322

Karger

Access to resources Recommend Favorite

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 331-340

Karger

Access to resources Recommend Favorite

Magnetic Resonance Imaging of the Cervix, and its Relevance to the Revised International Federation of Gynecology and Obstetrics (FIGO) Staging

By  

Current Medical Imaging Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 100-106

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer

By  

Current Women's Health Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 44-50

Bentham Science Publishers

Access to resources Recommend Favorite

Dose Escalation of Carboplatin and Cyclophosphamide Supported by GM-CSF in the Treatment of Patients with Advanced Ovarian Cancer (FIGO III and IV) – a Phase I Study

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 502-506

Karger

Access to resources Recommend Favorite